These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 21554876

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis.
    Dziadek B, Gatkowska J, Brzostek A, Dziadek J, Dzitko K, Dlugonska H.
    Exp Parasitol; 2009 Sep; 123(1):81-9. PubMed ID: 19508869
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
    Cong H, Gu QM, Jiang Y, He SY, Zhou HY, Yang TT, Li Y, Zhao QL.
    Parasite Immunol; 2005 Sep; 27(1-2):29-35. PubMed ID: 15813720
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii.
    Xue M, He S, Cui Y, Yao Y, Wang H.
    Parasitol Int; 2008 Dec; 57(4):424-9. PubMed ID: 18562245
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Studies on the immuno-protection of ROP2 nuclei acid vaccine in Toxoplasma gondii infection].
    Wei QK, Li J, Fu TX, Bai XL, Cui Y, Zhang DB, Wang HF, Liu YB, Fu B, Zai DF, Huang BC, Liu KY, Han GD.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Oct; 24(5):337-41. PubMed ID: 17361811
    [Abstract] [Full Text] [Related]

  • 14. A heterologous prime-boost vaccination regime using DNA and a vaccinia virus, both expressing GRA4, induced protective immunity against Toxoplasma gondii infection in mice.
    Zhang G, Huong VT, Battur B, Zhou J, Zhang H, Liao M, Kawase O, Lee EG, Dautu G, Igarashi M, Nishikawa Y, Xuan X.
    Parasitology; 2007 Sep; 134(Pt 10):1339-46. PubMed ID: 17506929
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CpG-containing ODN has a limited role in the protection against Toxoplasma gondii.
    Saavedra R, Leyva R, Tenorio EP, Haces ML, Rodríguez-Sosa M, Terrazas LI, Hérion P.
    Parasite Immunol; 2004 Feb; 26(2):67-73. PubMed ID: 15225293
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Vaccination with Leishmania soluble antigen and immunostimulatory oligodeoxynucleotides induces specific immunity and protection against Leishmania donovani infection.
    Tewary P, Pandya J, Mehta J, Sukumaran B, Madhubala R.
    FEMS Immunol Med Microbiol; 2004 Oct 01; 42(2):241-8. PubMed ID: 15364110
    [Abstract] [Full Text] [Related]

  • 20. Comparison of cholera toxin A2/B and murine interleukin-12 as adjuvants of Toxoplasma multi-antigenic SAG1-ROP2 DNA vaccine.
    Xue M, He S, Zhang J, Cui Y, Yao Y, Wang H.
    Exp Parasitol; 2008 Jul 01; 119(3):352-7. PubMed ID: 18442818
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.